Literature DB >> 10367851

Prostate cancer: demographic and behavioral correlates of stage at diagnosis among blacks and whites in North Carolina.

E A Conlisk1, E J Lengerich, W Demark-Wahnefried, J M Schildkraut, T E Aldrich.   

Abstract

OBJECTIVES: Although stage at diagnosis is one of the most important predictors of survival from prostate cancer, demographic factors, screening practices, and knowledge and beliefs associated with stage at diagnosis have not been well documented, particularly by race.
METHODS: We conducted telephone interviews with 117 black and 114 white men diagnosed with prostate cancer to identify the demographic factors, healthcare-seeking behaviors, and prostate cancer-related knowledge, attitudes, and practices associated with stage. The sample was stratified by stage at diagnosis and was composed of men 50 to 74 years old who resided in a contiguous 63-county region in North Carolina and who were diagnosed at 1 of 16 participating hospitals.
RESULTS: Among blacks, stage was inversely correlated with income (P = 0.04) and health insurance status (P < or = 0.001); among whites, stage was not associated with income or health insurance status, but approached significance with marital status (P = 0.06). Awareness of prostate cancer before diagnosis tended to decline with advancing stage among black men (P = 0.07), but was high for all stages (greater than 93%) among whites. Report of a prostate-specific antigen screen was inversely correlated with stage among black men (P = 0.01); a trend was observed among whites but was not significant (P = 0.20). Knowledge of prostate cancer risk factors was not significantly associated with stage for blacks or whites. Less than one third of men in each race and stage group knew that black men are at increased risk of prostate cancer.
CONCLUSIONS: Demographic and other factors vary with stage and should be considered when designing and targeting interventions to reduce late diagnosis of prostate cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10367851     DOI: 10.1016/s0090-4295(99)00005-9

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  12 in total

Review 1.  Managing the low-socioeconomic-status prostate cancer patient.

Authors:  Walter Rayford
Journal:  J Natl Med Assoc       Date:  2006-04       Impact factor: 1.798

2.  Awareness and use of the prostate-specific antigen test among African-American men.

Authors:  Louie E Ross; Robert J Uhler; Kymber N Williams
Journal:  J Natl Med Assoc       Date:  2005-07       Impact factor: 1.798

3.  An international comparison of cancer survival: metropolitan Toronto, Ontario, and Honolulu, Hawaii.

Authors:  K M Gorey; E J Holowaty; G Fehringer; E Laukkanen; N L Richter; C M Meyer
Journal:  Am J Public Health       Date:  2000-12       Impact factor: 9.308

4.  Understanding the psychosocial issues of African American couples surviving prostate cancer.

Authors:  Brian M Rivers; Euna M August; Gwendolyn P Quinn; Clement K Gwede; Julio M Pow-Sang; B Lee Green; Paul B Jacobsen
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

5.  Development of a scale to assess patient misperceptions about treatment choices for localized prostate cancer.

Authors:  Hind A Beydoun; Ravinder Mohan; May A Beydoun; John Davis; Raymond Lance; Paul Schellhammer
Journal:  BJU Int       Date:  2010-02-11       Impact factor: 5.588

6.  Predictors of new screening for African American men participating in a prostate cancer educational program.

Authors:  Janice S Emerson; Michelle C Reece; Robert S Levine; Pamela C Hull; Baqar A Husaini
Journal:  J Cancer Educ       Date:  2009       Impact factor: 2.037

7.  Characteristics and outcome of prostate cancer with PSA <4 ng/ml at diagnosis: a population-based study.

Authors:  M Bonet; A Merglen; G Fioretta; E Rapiti; I Neyroud-Caspar; R Zanetti; R Miralbell; C Bouchardy
Journal:  Clin Transl Oncol       Date:  2009-05       Impact factor: 3.405

8.  Impact of androgen deprivation therapy on racial/ethnic disparities in the survival of older men treated for locoregional prostate cancer.

Authors:  Laurens Holmes; Wenyaw Chan; Zhidong Jiang; Doriel Ward; E James Essien; Xianglin L Du
Journal:  Cancer Control       Date:  2009-04       Impact factor: 3.302

9.  Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH database.

Authors:  Lionel L Bañez; Martha K Terris; William J Aronson; Joseph C Presti; Christopher J Kane; Christopher L Amling; Stephen J Freedland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

10.  Black men have lower rates than white men of biochemical failure with primary androgen-deprivation therapy.

Authors:  Pejvak Sassani; Jeremy M Blumberg; T Craig Cheetham; Fang Niu; Stephen G Williams; Gary W Chien
Journal:  Perm J       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.